Filing Details
- Accession Number:
- 0000885590-12-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-08 19:15:53
- Reporting Period:
- 2012-03-07
- Filing Date:
- 2012-03-08
- Accepted Time:
- 2012-03-08 19:15:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1542052 | Susan Hall | Valeant Pharmaceuticals International 7150 Mississauga Road Mississauga A6 L5N 8M5 | Global Head Of R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2012-03-07 | 16,120 | $13.24 | 16,120 | No | 4 | A | Direct | |
| Common Stock, No Par Value | Disposition | 2012-03-07 | 16,120 | $54.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Non-Qualified Stock Options (right to purchase) | Acquisiton | 2012-03-07 | 16,120 | $0.00 | 16,120 | $13.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 32,240 | 2012-03-03 | 2017-03-03 | No | 4 | M | Direct |
Billionaire Hedge Funds
